Aim: The present study was undertaken to explore the pharmacological potential of Chalcone derivatives through a comprehensive in silico approach. A thorough review of reputed pharmaceutical and biomedical databases such as PubMed and Scopus revealed a significant research gap pertaining to Chalcone molecules, largely due to limited substitutions, synthetic challenges, and their underrepresentation in mainstream medicinal chemistry. Consequently, this study aims to address the vacuum in pharmacodynamics, pharmacokinetics, toxicity, metabolite behavior, and molecular interactions of Chalcones by employing a multi-tool computational analysis. Methodology: Molecular docking studies were performed using AutoDock Vina to assess the binding efficiency against a specific disease target. Complementary investigations included network pharmacology, molecular simulations, and structure-activity relationship (SAR)-based analyses. Results: The study successfully identified high-affinity Chalcone derivatives with promising Glide Scores and pharmacokinetic profiles. Target prediction studies revealed potential biological targets with plausible therapeutic relevance. QuikProp analysis indicated that most derivatives adhered to key drug-likeness criteria. Toxicity prediction tools outlined acceptable safety margins for selected molecules, with manageable IC50 and LD50 values. Bioisosteric modification improved pharmacokinetic profiles in select derivatives. Metabolism studies suggested viable biotransformation pathways and potential active metabolites. Interaction studies demonstrated low risk of adverse food or drug interactions, increasing their candidacy as future therapeutic agents. Conclusion: This research provides a detailed computational insight into the therapeutic promise of Chalcone molecules by employing a wide range of free and accessible in silico tools. The findings not only bridge existing knowledge gaps in Chalcone pharmacology but also offer a practical guide for future experimental validation.